Wake Forest University Health Sciences — Charlotte, North Carolina

Public research footprint of Wake Forest University Health Sciences, compiled from the ClinicalTrials.gov public registry.

318

Registered studies

139

Active

Recruiting now

150

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Recurrent Skin Squamous Cell Carcinoma With Sarcomatoid… · Stage IB Lung Non-Small Cell Carcinoma AJCC v7

Recently updated registry entries

NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT07061977 — Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… (Recruiting)
NCT06064097 — A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Wake Forest University Health Sciences?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.